Related Experiment Video
Updated: Jun 30, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Amiodarone Induced Ventricular Fibrillation in Unveiled WPW Syndrome: A Resource-Limited Setting Dilemma
Fadhlan Abdur Rahman1, Natasya Febrilia Yulianti1, Abdul Gofur2
1Citra Husada Jember Hospital, Jember, East Java, Indonesia.
Background:
Wolff-Parkinson-White (WPW) syndrome predisposes patients to life-threatening tachyarrhythmias due to rapid ventricular activation via an accessory pathway. Malignant arrhythmias may occur unexpectedly, even in previously asymptomatic individuals.
Case Summary:
A 36-year-old man presented with sudden palpitations and a regular wide-complex tachycardia consistent with antidromic atrioventricular reentrant tachycardia. The rhythm rapidly deteriorated into preexcited atrial fibrillation and progressed to ventricular fibrillation cardiac arrest requiring immediate defibrillation and cardiopulmonary resuscitation, with successful return of spontaneous circulation. Postresuscitation electrocardiography demonstrated persistent ventricular preexcitation. Electrophysiological study subsequently confirmed a left lateral accessory pathway, and successful radiofrequency catheter ablation resulted in complete resolution of ventricular preexcitation.
Discussion:
This case highlights the malignant electrophysiological behavior of WPW and the diagnostic and therapeutic challenges of wide-complex tachycardia, particularly in resource-limited settings.
Take-Home Messages:
WPW may rapidly progress from antidromic atrioventricular reentrant tachycardia to ventricular fibrillation. Early recognition, prompt electrical cardioversion/defibrillation, and timely referral for catheter ablation are critical.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias I: Introduction
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

